News | May 12, 2026
JB Chemicals reports muted Q4 FY26 as integration resets business
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The Union Minister reviewed DST-supported SATHI-BHU facility
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
